Literature DB >> 31676160

Life Expectancy after Stroke Based On Age, Sex, and Rankin Grade of Disability: A Synthesis.

Robert M Shavelle1, Jordan C Brooks2, David J Strauss2, Lynne Turner-Stokes3.   

Abstract

BACKGROUND: Stroke is a leading cause of death and disability in the developed world. The major factor affecting long term survival (other than age) is known to be the severity of disability. Yet to our knowledge there are no studies reporting life expectancies stratified by both age and severity. Remaining life expectancy is a key measure of health.
METHODS: We identified 11 long-term follow-up studies of stroke patients that reported the multivariate effects of age, sex, the modified Rankin Scale (mRS) grade of disability, and other factors. From these we computed the composite effects of these factors on survival, then used these to calculate age-, sex-, and mRS-specific mortality rates. Finally we used the rates to construct life tables, and hence obtain life expectancies.
RESULTS: Life expectancy varies by age, sex, and mRS. The life expectancies of males age 70, for example, were 13, 13, 11, 8, 6, and 5 years for Rankin Grades 0-5, respectively, representing reductions of 1, 1, 3, 6, 8, and 9 years from the corresponding general population figure.
CONCLUSIONS: These figures demonstrate the importance of rehabilitation following stroke, and can be used in discussion of public policy and benchmarking of future results.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Survival; cerebrovascular disease; epidemiology; hemorrhagic; intracranial hemorrhage; ischemic; life table; severity

Mesh:

Year:  2019        PMID: 31676160     DOI: 10.1016/j.jstrokecerebrovasdis.2019.104450

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  4 in total

1.  Resilience and Its Association With Activities of Daily Living 3 Months After Stroke.

Authors:  Ole Petter Norvang; Anne Eitrem Dahl; Pernille Thingstad; Torunn Askim
Journal:  Front Neurol       Date:  2022-06-14       Impact factor: 4.086

2.  Cost-Effectiveness of Cilostazol Added to Aspirin or Clopidogrel for Secondary Prevention After Noncardioembolic Stroke.

Authors:  Lily W Zhou; Lironn Kraler; Adam de Havenon; Maarten G Lansberg
Journal:  J Am Heart Assoc       Date:  2022-06-03       Impact factor: 6.106

3.  Effects of N-Pep-12 dietary supplementation on neurorecovery after ischemic stroke.

Authors:  Maria Balea; Codruta Birle; Cezara Costin; Julia Marton; Ioana Anamaria Muresanu; Nicoleta Jemna; Livia Livint Popa; Dana Slavoaca; Olivia Verisezan Rosu; Adina Stan; Vitalie Vacaras; Stefan Strilciuc; Dafin F Muresanu
Journal:  Neurol Sci       Date:  2020-10-02       Impact factor: 3.307

4.  N-Pep-12 supplementation after ischemic stroke positively impacts frequency domain QEEG.

Authors:  Livia Livint Popa; Mihaela Iancu; Gheorghe Livint; Maria Balea; Constantin Dina; Vitalie Vacaras; Cristian Vladescu; Laura Balanescu; Anca Dana Buzoianu; Stefan Strilciuc; Dafin Muresanu
Journal:  Neurol Sci       Date:  2021-06-25       Impact factor: 3.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.